Tag Archives: another

Sorry, Allergan. Another activist backs an immediate split to CEO, chairman jobs

If Allergan thought it could satisfy angry investors by splitting the CEO and chairman jobs after Brent Saunders leaves the company, it’ll have to think again. Another prominent activist—John Chevedden—is joining forces with rebels at Appaloosa to push for an immediate split.   Appaloosa said Thursday that Chevedden is withdrawing his shareholder resolution for a job split and backing its own. Chevedden said… Read More »

Merck suits up for another Opdivo showdown with Keytruda liver cancer approval

Merck just advanced the Keytruda-Opdivo immuno-oncology rivalry into a brand-new arena. On Friday, the FDA handed Keytruda a new approval in patients with hepatocellular carcinoma—the most common form of liver cancer in adults—who have already been treated with Bayer’s Nexavar. That’s a group for which regulators cleared Opdivo, Keytruda’s chief nemesis in the PD-1/PD-L1 class,… Read More »

  1. Pages:
  3. 1
  4. 2